Clinical Trial Update: Fimasartan (BR-A-657) Multiple Oral Dose in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 multiple-ascending-dose study of fimasartan (BR-A-657) in healthy subjects to evaluate safety, tolerability, and pharmacokinetics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Fimasartan (fimasartan)

Snippet

Sponsor: Boryung Pharmaceutical Co., Ltd | Conditions: Essential Hypertension | Phase 1 | Status: COMPLETED